Freenome, Inc. - Common stock (FRNM)

11.62
+0.47 (4.22%)
NASDAQ· Last Trade: Aug 10th, 4:22 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close11.15
Open11.15
Bid11.60
Ask11.62
Day's Range11.04 - 11.95
52 Week Range9.970 - 14.26
Volume898,538
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume768,636

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026